Escalon Medical Corp financial data

Symbol
ESMC on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
435 Devon Park Road, Suite 824, Wayne, Pennsylvania
State of incorporation
Pennsylvania
Fiscal year end
June 30
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 163 % +18%
Quick Ratio 59.4 % +4.46%
Debt-to-equity 165 % -36.3%
Return On Equity -3.33 % -114%
Return On Assets -1.25 % -119%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.42M shares 0%
Common Stock, Shares, Outstanding 7.42M shares 0%
Entity Public Float 178K USD -45.5%
Common Stock, Value, Issued 7.42K USD 0%
Weighted Average Number of Shares Outstanding, Basic 7.42M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 7.42M shares -45%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.7M USD -21.5%
Research and Development Expense 693K USD -18.6%
Costs and Expenses 11.7M USD +0.49%
Operating Income (Loss) -37.9K USD -112%
Nonoperating Income (Expense) -22.2K USD -9.14%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -61.3K USD -118%
Earnings Per Share, Basic -0.03 USD/shares -175%
Earnings Per Share, Diluted 0.01 USD/shares -50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 565K USD +3.75%
Accounts Receivable, after Allowance for Credit Loss, Current 1.65M USD +7.26%
Inventory, Net 1.8M USD +8.39%
Other Assets, Current 167K USD +2.68%
Assets, Current 4.15M USD -5.01%
Property, Plant and Equipment, Net 54K USD +35.2%
Operating Lease, Right-of-Use Asset 276K USD -51.8%
Assets 4.6M USD -10.2%
Accounts Payable, Current 1.12M USD +6.7%
Employee-related Liabilities, Current 471K USD +5.67%
Accrued Liabilities, Current 590K USD -32.1%
Contract with Customer, Liability, Current 213K USD +230%
Liabilities, Current 2.63M USD -5.27%
Operating Lease, Liability, Noncurrent 16K USD -94.5%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 2.92M USD -13.6%
Retained Earnings (Accumulated Deficit) -68.7M USD -0.09%
Stockholders' Equity Attributable to Parent 1.68M USD -3.53%
Liabilities and Equity 4.6M USD -10.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -116K USD +62.6%
Net Cash Provided by (Used in) Financing Activities -10.5K USD -795%
Net Cash Provided by (Used in) Investing Activities -18.3K USD -156%
Common Stock, Shares Authorized 35M shares 0%
Common Stock, Shares, Issued 7.42M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -145K USD +54.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 821K USD +2.57%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.58K USD +5.86%
Deferred Tax Assets, Valuation Allowance 7.55M USD -1.24%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 7.74M USD +1%
Payments to Acquire Property, Plant, and Equipment 18.3K USD
Lessee, Operating Lease, Liability, to be Paid 308K USD -52.7%
Property, Plant and Equipment, Gross 945K USD +0.71%
Operating Lease, Liability, Current 283K USD -12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 212K USD +146%
Lessee, Operating Lease, Liability, to be Paid, Year One 88.5K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.93K USD -98.9%
Deferred Tax Assets, Operating Loss Carryforwards 7.03M USD -5.41%
Preferred Stock, Shares Issued 2M shares 0%
Deferred Federal Income Tax Expense (Benefit) 64.4K USD
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.2K USD -99.4%
Additional Paid in Capital 69.7M USD 0%
Depreciation, Depletion and Amortization 11K USD -3.97%
Deferred Tax Assets, Net of Valuation Allowance 189K USD +988%
Deferred State and Local Income Tax Expense (Benefit) 30.7K USD
Interest Expense 23.5K USD +13.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%